Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?

J Am Coll Cardiol. 2022 Apr 12;79(14):1382-1384. doi: 10.1016/j.jacc.2022.01.043.

Authors

Jonathan P Piccini¹, Josephine Harrington²

Affiliations

¹ Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA. Electronic address: jonathan.piccini@duke.edu.
² Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA. Electronic address: https://twitter.com/JLHarrington_MD.

PMID: 35393019
DOI: 10.1016/j.jacc.2022.01.043

No abstract available

Keywords: atrial fibrillation; biomarker; ischemic stroke; midregional pro-atrial natriuretic peptide; risk prediction; stroke etiology.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Atrial Fibrillation* / diagnosis
Atrial Natriuretic Factor*
Biomarkers
Humans
Natriuretic Peptide, Brain
Peptide Fragments

Substances

Biomarkers
Peptide Fragments
Natriuretic Peptide, Brain
Atrial Natriuretic Factor

Grants and funding